NASDAQ: NBP
Novabridge Biosciences Stock Ownership - Who owns Novabridge Biosciences?

Insider buying vs selling

Have Novabridge Biosciences insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NBP insiders and whales buy or sell their stock.

NBP Shareholders

What type of owners hold Novabridge Biosciences stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hhlr Advisors Ltd3.18%5,980,568$28.26MInstitution
Candriam Sca0.60%1,132,563$5.35MInstitution
Sg Americas Securities LLC0.47%876,353$4.14MInstitution
Two Sigma Advisers LP0.11%209,383$989.33kInstitution
Ubs Group Ag0.10%184,845$873.39kInstitution
Aberdeen Group PLC0.07%136,471$644.83kInstitution
Bnp Paribas Financial Markets0.07%122,405$578.36kInstitution
Two Sigma Investments LP0.06%113,262$535.16kInstitution
Ariose Capital Management Ltd0.05%96,455$455.75kInstitution
Alberta Investment Management Corp0.04%74,723$353.07kInstitution

1 of 3

NBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBP4.99%0.00%
DMAC16.96%69.86%Net BuyingNet Buying
AURA81.48%15.23%Net SellingNet Selling
RCKT50.25%49.75%Net SellingNet Selling
DSGN45.90%54.10%Net SellingNet Selling

Novabridge Biosciences Stock Ownership FAQ

Who owns Novabridge Biosciences?

Novabridge Biosciences (NASDAQ: NBP) is owned by 4.99% institutional shareholders, 0.00% Novabridge Biosciences insiders, and 95.01% retail investors. Hhlr Advisors Ltd is the largest individual Novabridge Biosciences shareholder, owning 5.98M shares representing 3.18% of the company. Hhlr Advisors Ltd's Novabridge Biosciences shares are currently valued at $25.54M.

If you're new to stock investing, here's how to buy Novabridge Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.